PAR 41.5% 46.0¢ paradigm biopharmaceuticals limited..

FA bagger potential, page-46

  1. 16 Posts.
    lightbulb Created with Sketch. 3
    Vets have been using injectable PPS (with great results) for maybe 20 years and have been scratching their heads as to why the stuff hasn't become a similar, but much larger scale, success story in the human market. There has long been at least 3 products (I thought manufacturers) to choose from, the drug being marketed variously as Cartrophen Vet, Pentosan and Zydax.
    How does this plethora of options square with PAR having exclusive rights for 20 years from the only manufacturer in the world? I know nothing about how such things work and, although I have been waiting to jump on the bandwagon, it does make me somewhat sceptical.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
46.0¢
Change
0.135(41.5%)
Mkt cap ! $82.30M
Open High Low Value Volume
34.0¢ 49.5¢ 34.0¢ $3.506M 8.474M

Buyers (Bids)

No. Vol. Price($)
1 10000 45.5¢
 

Sellers (Offers)

Price($) Vol. No.
46.0¢ 147167 1
View Market Depth
Last trade - 16.10pm 25/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.